Clinical Trials in Dallas

Showing 2761-2780 of 17,468 trials

Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC

NCT01995058

This study was conducted in subjects in chemotherapy-naïve subjects with bone-metastatic castration-resistant prostate cancer (CRPC).

Prostate CancerCastration Resistant Prostate CancerProstatic Neoplasms

Exelixis54 participantsStarted Feb 2014

Scottsdale, Arizona, United States • Sedona, Arizona, United States • Tucson, Arizona, United States +17 more locations

TERMINATEDPhase 3< 1 mile

A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma

NCT05002569

The purpose of this study is to assess nivolumab plus relatlimab fixed-dose combination (FDC) versus nivolumab alone in participants with completely resected stage III-IV melanoma.

Melanoma

Bristol-Myers Squibb1,093 participantsStarted Oct 2021

Birmingham, Alabama, United States • Springdale, Arkansas, United States • Los Angeles, California, United States +181 more locations

Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC

A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma

Find Trials by Condition in Dallas

The PATHway Study: Primary Care Based Depression Prevention in Adolescents

Risk Indicators of Sarcoidosis Evolution-Unified Protocol

Investigation of the Two Level Simplify® Cervical Artificial Disc

Post Approval Study Protocol for the Two Level Simplify® Cervical Artificial Disc

Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study

Abbott DBS Post-Market Study of Outcomes for Indications Over Time

STimulation to Activate RespIration

Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study

A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia

Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia

Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita

RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE

Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP

Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone

A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma

CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes

A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome

A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors